Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Baird Small/Mid Cap Growth lagged a speculative, beta-driven benchmark rally in Q2 2025 (+4.46% net vs. +11.31%), but continues to focus on high-quality compounders while actively upgrading portfolio quality through selective healthcare and consumer additions.
Full Quick Take
Baird Small/Mid Cap Growth lagged a speculative, beta-driven benchmark rally in Q2 2025 (+4.46% net vs. +11.31%), but continues to focus on high-quality compounders while actively upgrading portfolio quality through selective healthcare and consumer additions.
